(Total Views: 68)
Posted On: 05/06/2024 8:55:57 AM
Post# of 27085
$EYPT News Article - EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU(TM) in Non-Proliferative Diabetic Retinopathy https://marketwirenews.com/news-releases/eyep...44779.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
